These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7486588)

  • 21. Antigen recognition by an antibody light chain.
    Sun M; Li L; Gao QS; Paul S
    J Biol Chem; 1994 Jan; 269(1):734-8. PubMed ID: 8276876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of high thermostability and peroxidase activity of recombinant antibody L chain-porphyrin Fe(III) complex.
    Kohda K; Kakehi M; Ohtsuji Y; Tagaki M; Imanaka T
    FEBS Lett; 1997 May; 407(3):280-4. PubMed ID: 9175868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational analysis of the affinity maturation of antibody 48G7.
    Yang PL; Schultz PG
    J Mol Biol; 1999 Dec; 294(5):1191-201. PubMed ID: 10600377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display.
    Tyutyulkova S; Gao QS; Thompson A; Rennard S; Paul S
    Biochim Biophys Acta; 1996 Aug; 1316(3):217-23. PubMed ID: 8781541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid purification of recombinant antibody fragments for catalysis screening.
    Huang H; Fichter B; Dannenbring R; Paul S
    Methods Mol Biol; 1995; 51():403-7. PubMed ID: 7581712
    [No Abstract]   [Full Text] [Related]  

  • 26. [Expression of the catalytically active light chain of the antibody against vasoactive intestinal peptide].
    Demin AV; Kolesnikov AV; Olfer'ev MA; Favorov PV; Fegeding KV; Gabibov AG; Gnuchev NV
    Dokl Akad Nauk; 1998 Jun; 360(4):547-9. PubMed ID: 9702507
    [No Abstract]   [Full Text] [Related]  

  • 27. DNA hydrolysis by monoclonal autoantibody BV 04-01.
    Rodkey LS; Gololobov G; Rumbley CA; Rumbley J; Schourov DV; Makarevich OI; Gabibov AG; Voss EW
    Appl Biochem Biotechnol; 2000; 83(1-3):95-103; discussion 103-5, 145-53. PubMed ID: 10826952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
    Mitsuda Y; Hifumi E; Tsuruhata K; Fujinami H; Yamamoto N; Uda T
    Biotechnol Bioeng; 2004 Apr; 86(2):217-25. PubMed ID: 15052642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of reduced and alkylated antibody subunits.
    Sun M; Paul S
    Methods Mol Biol; 1995; 51():111-22. PubMed ID: 7581690
    [No Abstract]   [Full Text] [Related]  

  • 31. Catalytic features of monoclonal antibody i41SL1-2 subunits.
    Hifumi E; Kondo H; Mitsuda Y; Uda T
    Biotechnol Bioeng; 2003 Nov; 84(4):485-93. PubMed ID: 14574707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyreactivity of natural antibodies: exchange by HL-fragments.
    Sedykh MA; Buneva VN; Nevinsky GA
    Biochemistry (Mosc); 2013 Dec; 78(12):1305-20. PubMed ID: 24460965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel method of preparing the monoform structure of catalytic antibody light chain.
    Hifumi E; Matsumoto S; Nakashima H; Itonaga S; Arakawa M; Katayama Y; Kato R; Uda T
    FASEB J; 2016 Feb; 30(2):895-908. PubMed ID: 26527062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
    Li Y; Li H; Smith-Gill SJ; Mariuzza RA
    Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New variation on a theme: structure and mechanism of action of hydrolytic antibody 7F11, an aspartate rich relation of catalytic antibodies 17E8 and 29G11.
    Cross SS; Brady K; Stevenson JD; Sackin JR; Kenward N; Dietel A; Thomas NR
    J Immunol Methods; 2002 Nov; 269(1-2):173-95. PubMed ID: 12379361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody.
    Lefevre S; Debat H; Thomas D; Friboulet A; Avalle B
    FEBS Lett; 2001 Jan; 489(1):25-8. PubMed ID: 11231007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement.
    Mundorff EC; Hanson MA; Varvak A; Ulrich H; Schultz PG; Stevens RC
    Biochemistry; 2000 Feb; 39(4):627-32. PubMed ID: 10651626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombin cleaving antibody light chains.
    Thiagarajan P; Paul S
    Chem Immunol; 2000; 77():115-29. PubMed ID: 11706702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.